A once-in-a-decade opportunity to buy these ASX 200 growth shares before they rocket?

Is now the time to seize on market weakness to buy these highly rated stocks?

| More on:
A group of people in suits watch as a man puts his hand up to take the opportunity.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I think it is fair to say that the past few weeks have been difficult for investors. Particularly those that invest in ASX 200 growth shares.

The dramatic selloff has seen many shares retreating sharply from their recent highs.

While it is disappointing to see your portfolio shed value, every cloud has a silver lining.

The silver lining here is that it could have created a once-in-a-decade opportunity that investors have been waiting for – a chance to buy quality ASX 200 growth shares at a discount before they rebound and potentially rocket to new highs.

But which growth shares could be worth buying right now? Let's take a look at three that analysts are tipping as buys. They are as follows:

Lovisa Holdings Ltd (ASX: LOV)

The first ASX 200 growth share to consider buying after the selloff is Lovisa. This fashion jewellery retailer's shares have pulled back by over 7% from recent highs.

Analysts at Morgans will see this as a buying opportunity. Following a similar pullback at the end of last year, the broker commented: "Lovisa has proven it can successfully build out its unique brand in many diverse territories around the world on its journey to becoming a truly global brand. It's at times like these that investors should be getting set to reap the rewards of this strategy over the longer term."

Morgans has an add rating and $37.00 price target on its shares.

Pro Medicus Limited (ASX: PME)

Another ASX 200 growth share that was dragged lower during the market selloff is Pro Medicus. It is a leading provider of radiology information systems (RIS), Picture Archiving and Communication Systems (PACS), and advanced visualisation solutions across the globe.

Analysts at Goldman Sachs are likely to see this pullback as a great opportunity for investors to buy this high quality company. Particularly given how the broker sees "PME as the clear incumbent technology leader in a growing market with a strong financial profile and significant AI upside."

It has a buy rating and $148.00 price target on its shares.

Xero Ltd (ASX: XRO)

A final stock that could be a top option for investors is Xero. This leading cloud-based accounting software provider is another ASX 200 growth share that has been caught up in the recent selloff.

However, despite the near-term volatility, Xero's long-term growth prospects remain very bright thanks to the structural shift to the cloud. In fact, Goldman Sachs estimates that it has a total addressable market of 100 million small to medium sized businesses. This compares to its current subscriber base of 4.2 million.

Goldman believes this gives it a multi-decade growth runway. It is no surprise then that it is tipping its shares as a buy with a $180.00 price target.

Motley Fool contributor James Mickleboro has positions in Lovisa, Pro Medicus, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Lovisa, Pro Medicus, and Xero. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool Australia has recommended Lovisa and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

happy investor, share price rise, increase, up
Growth Shares

3 fantastic ASX 200 growth shares to buy in 2025

Analysts have good things to say about these buy-rated shares.

Read more »

Smiling couple looking at a phone at a bargain opportunity.
Growth Shares

The ASX 200 stock with 'a $200 billion gross profit opportunity'

Experts believe this stock has excellent potential.

Read more »

A young girl and boy drinking milk in a garden setting
Growth Shares

2 ASX growth shares set to skyrocket in the next 12 months

These stocks have a lot of potential according to experts.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Growth Shares

2 no-brainer ASX 200 shares to consider buying with just $1,000

Analysts rate these top stocks very highly. Let's find out why.

Read more »

A happy laughing surfer couple surfing together.
Growth Shares

If I were in my 20s, I'd buy these ASX shares for growth

I think these investments could be great picks for younger Aussies.

Read more »

Hand holding Australian dollar (AUD) bills, symbolising ex dividend day. Passive income.
Growth Shares

Invest $5,000 into these ASX 200 shares in 2025

Analysts think these shares could be top options for an investment in 2025.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Growth Shares

3 explosive ASX growth shares to buy now

Analysts have good things to say about these growth shares.

Read more »

Happy man holding Australian dollar notes, representing dividends.
Growth Shares

Invest $5,000 into these ASX 200 growth shares in December

Analysts at Bell Potter and Goldman Sachs are bullish on these names.

Read more »